Orbis Medicines
The Senior Scientist will lead peptide chemistry and macrocyclic library production within Orbis Medicines' Platform Chemistry team, integrating experimental workflows with AI-driven drug design. The role involves planning and executing complex synthesis projects, improving platform capabilities, and collaborating across multidisciplinary teams to advance drug discovery programs.
Orbis Medicines is a biopharmaceutical company focused on oral macrocycle drug discovery, developing next-generation small molecule drugs called nCycles that can target diseases traditionally treated with injectable biologic therapies. The company's proprietary nGen platform uses high-throughput chemistry, DNA-encoded libraries, and AI-driven deep learning to systematically explore macrocycle chemical space and identify orally bioavailable drug candidates. Orbis Medicines aims to provide oral alternatives to blockbuster biologic drugs, enabling treatment of a broader patient population across multiple therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orbis Medicines.
Orbis Medicines didn’t post a salary, so this is our estimate from similar listings.
11% below the average for this role
Research or Senior Scientist - Peptide Chemistry
City of Pierre, South Dakota
Scientist I or II - Peptide Chemistry
City of Pierre, South Dakota
Scientist – Peptide Chemistry
AstraZeneca
Director/Senior Director, Medicinal Chemistry
Eli Lilly and Company
Scientist
Arrowhead Pharmaceuticals
Research or Senior Scientist - Peptide Chemistry
City of Winnipeg